Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Ibuprofen and Pseudoephedrine Liquid Capsules vs Tablets
NCT03184766Phase 1Completed
- Sponsor
- Reckitt
- Start
- Aug 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ibuprofen and pseudoephedrine in common cold and influenza (6 arms), sponsored by Reckitt. Primary endpoints: Pseudoephedrine Area Under the Curve from time 0 to last measurable concentration, Pseudoephedrine Maximum Plasma Concentration and 2 more. Started Aug 2016; status: completed.
02
Drugs
ibuprofenpseudoephedrine
03
Conditions
common coldinfluenza
Beyond the preview
Go deeper on NCT03184766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03184766.